Edition:
United States

Rhoen Klinikum AG (RHKG.DE)

RHKG.DE on Xetra

26.68EUR
26 May 2017
Change (% chg)

€0.18 (+0.68%)
Prev Close
€26.50
Open
€26.49
Day's High
€26.71
Day's Low
€26.45
Volume
65,070
Avg. Vol
141,217
52-wk High
€27.99
52-wk Low
€22.66

Latest Key Developments (Source: Significant Developments)

Asklepios owner ups stake in Rhoen-Klinikum to 25.1 percent
Monday, 22 May 2017 11:05am EDT 

May 22 (Reuters) - Rhoen Klinikum Ag :Says in filing that Asklepios owner Broermann's holding rises to 25.1 percent from 20.2 percent.  Full Article

Rhoen Klinikum, UKGM, Federal State of Hesse and Universities of Giessen and Marburg achieve agreement in separate accounting
Friday, 19 May 2017 07:10am EDT 

May 19 (Reuters) - RHOEN KLINIKUM AG ::SAYS UKGM, FEDERAL STATE OF HESSE AND UNIVERSITIES OF GIESSEN AND MARBURG ACHIEVE GROUND-BREAKING AGREEMENT IN SEPARATE ACCOUNTING.SAYS UKGM RECEIVES ADDITIONAL ANNUAL AMOUNT OF APPROX. EUR 15 MILLION FROM 2017 ONWARDS UP TO EUR 72.9 MILLION PER ANNUM IN FUTURE PLUS A SINGLE PAYMENT OF EUR 13 MILLION FOR INVESTMENTS.UKGM WILL INVEST APPROX. EUR 100 MILLION IN NEXT FIVE YEARS.SAYS UKGM WILL INVEST APPROX. EUR 100 MILLION IN NEXT FIVE YEARS.  Full Article

Rhön-Klinikum posts Q1 EBITDA of eur 25.5 million
Friday, 5 May 2017 12:59am EDT 

May 5 (Reuters) - Rhoen Klinikum Ag :Interim report for the first quarter of 2017: new board of management tackles main tasks - focus on raising profitability and putting campus concept into practice - outlook for 2017.Outlook for 2017: revenues between eur 1.20 billion and eur 1.23 billion, EBITDA between eur 85 million and eur 105 million.Q1 revenues amount to eur 300.1 million.Shall propose dividend from net consolidated profit in amount of eur 0.35 per non-par share.Q1 EBITDA stands at eur 25.5 million.  Full Article

Rhoen Klinikum proposes dividend of 0.35 euro per share
Friday, 7 Apr 2017 01:00am EDT 

Rhoen Klinikum AG : Dividend proposal in amount of 0.35 euro per share .Outlook for 2017: revenues between 1.20 billion and 1.23 billion euros ($1.28 billion - $1.31 billion).  Full Article

Rhoen Klinikum FY net consolidated profit was at EUR 58.6 mln
Friday, 24 Feb 2017 01:08am EST 

Rhoen Klinikum AG : FY corporate revenues stood at 1.18 billion euros ($1.25 billion) with earnings before interest, taxes, depreciation and amortisation (EBITDA) amounting to 156.9 million euros . FY EBITDA without these subsequent transaction effects amounted to 114.9 million euros . FY net consolidated profit was at 58.6 million euros . For current financial year 2017 expects regulatory legislation to place a burden on future business . For FY 2017 expects only modest organic growth and revenues of between 1.20 billion euros and 1.23 billion euros .EBITDA might be burdened in 2017 and be clearly lower in comparison with last year.  Full Article

Rhoen-Klinikum reduces size of management board
Thursday, 23 Feb 2017 06:22am EST 

Rhoen Klinikum AG : Reduces size of management board . To reduce size of management board from five to three members by revoking appointment of Martin Menger (operative business) and Jens-Peter Neumann (finance) to management board . Management board of company therefore consists of Stephan Holzinger (chairman), Martin Siebert (deputy chairman) and Bernd Griewing .In particular, Holzinger has also assumed responsibilities of CFO.  Full Article

Rhoen Klinikum: removal of management board members Martin Menger and Jens-Peter Neumann
Thursday, 16 Feb 2017 07:54am EST 

Rhoen Klinikum AG : Personnel committee of the supervisory board recommends reducing the management board by removing management board members Martin Menger and Jens-Peter Neumann .Rhoen klinikum - if supervisory board accepts this recommendation, management board of company will in future consist of Stephan Holzinger (chairman), Martin Siebert (deputy chairman) and Bernd Griewing.  Full Article

Rhoen Klinikum: value adjustment in connection with financial investment in MIT GmbH
Tuesday, 14 Feb 2017 09:17am EST 

Rhoen Klinikum AG : Value adjustment in connection with financial investment in mit gmbh in amount of approx. 35.5 million euros ($37.66 million) . Value adjustment results from operational delays in connection with initial operating phase of Marburg Ion Therapy Center .Resulting negative impact affects financial result and consolidated result 2016 by a corresponding amount.  Full Article

Rhoen Klinikum says plans to appoint Stephan Holzinger as new CEO
Thursday, 19 Jan 2017 12:20pm EST 

Rhoen Klinikum AG : dgap-adhoc: rhön-klinikum ag: decision making process of supervisory board of rhön- klinikum concerning reorganization of management board . Says in case resolution is passed, supervisory board would appoint Stephan Holzinger with effect as of 01 February 2017 as member of management board . Says together with his appointment to management board Stephan Holzinger would at same time become its chairman .Says Martin Siebert, who has been chairman so far, would become vice chairman of management board for personal reasons.  Full Article

Rhoen Klinikum: significant structural burdens on FY 2017 results
Thursday, 19 Jan 2017 06:04am EST 

Rhoen Klinikum AG : Management board expects since today significant structural burdens on results in a range of low to middle two digit millions for current financial year 2017 . Will adjust its regular financial forecast .Last year's financial results of company are positively affected by high one time effects.  Full Article

More From Around the Web

BRIEF-Asklepios owner ups stake in Rhoen-Klinikum to 25.1 percent

* Says in filing that Asklepios owner Broermann's holding rises to 25.1 percent from 20.2 percent Source text for Eikon: Further company coverage: